Peak6 LLC Invests $888,000 in Ardent Health Partners, LLC (NYSE:ARDT)

PEAK6 LLC acquired a new position in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 51,967 shares of the company's stock, valued at approximately $888,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. State Street Corp acquired a new position in Ardent Health Partners during the third quarter worth $1,977,000. Jane Street Group LLC acquired a new stake in shares of Ardent Health Partners during the 3rd quarter worth about $567,000. Barclays PLC acquired a new stake in shares of Ardent Health Partners during the 3rd quarter worth about $385,000. Geode Capital Management LLC acquired a new position in Ardent Health Partners in the third quarter valued at about $2,581,000. Finally, JPMorgan Chase & Co. bought a new stake in Ardent Health Partners during the third quarter worth about $154,000.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on ARDT shares. Mizuho decreased their price target on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Royal Bank of Canada decreased their target price on Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Tuesday, March 4th. Guggenheim assumed coverage on shares of Ardent Health Partners in a research report on Wednesday, April 9th. They set a "buy" rating and a $16.00 price target on the stock. Stephens restated an "overweight" rating and issued a $22.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, April 1st. Finally, Morgan Stanley dropped their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research note on Tuesday, January 21st. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $20.58.

Ardent Health Partners Stock Down 0.6 %

Shares of ARDT stock traded down $0.08 during trading hours on Friday, reaching $12.48. The company had a trading volume of 174,800 shares, compared to its average volume of 403,496. Ardent Health Partners, LLC has a 1-year low of $11.31 and a 1-year high of $20.72. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The company has a 50 day moving average of $13.34 and a 200 day moving average of $15.37.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.48 billion. On average, analysts anticipate that Ardent Health Partners, LLC will post 1.23 earnings per share for the current fiscal year.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.